Drug Shortage Report for MYLAN-BUPROPION XL

Last updated on 2019-06-19 History
Report ID 3941
Drug Identification Number 02382075
Brand name MYLAN-BUPROPION XL
Common or Proper name BUPROPION XL
Company Name MYLAN PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) BUPROPION HYDROCHLORIDE
Strength(s) 150MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size 90BT, 500BT
ATC code N06AX
ATC description ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-05-18
Actual start date 2018-05-04
Estimated end date 2019-09-30
Actual end date 2019-06-18
Shortage status Resolved
Updated date 2019-06-19
Company comments Manufacturing issues
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v127 2019-06-19 English Compare
v126 2019-06-18 French Compare
v125 2019-06-18 English Compare
v124 2019-05-14 French Compare
v123 2019-05-14 English Compare
v122 2019-05-08 French Compare
v121 2019-05-08 English Compare
v120 2019-02-01 French Compare
v119 2019-02-01 English Compare
v118 2018-11-21 French Compare
v117 2018-11-21 English Compare
v116 2018-11-21 French Compare
v115 2018-11-21 English Compare
v114 2018-11-06 French Compare
v113 2018-11-06 English Compare
v112 2018-10-23 French Compare
v111 2018-10-23 English Compare
v110 2018-10-03 French Compare
v109 2018-10-03 English Compare
v108 2018-09-24 French Compare

Showing 1 to 20 of 127